Immune cell infiltrates and prognosis in localized prostate cancer†

Abstract

Multiple lines of evidence indicate that quantification of immune cell infiltrates in primary prostate cancer can predict outcomes after radical prostatectomy, including biochemical recurrence, metastasis, and death from prostate cancer. In a recent issue of The Journal of Pathology, Andersen et al explored the predictive value of cancer tissue infiltration of seven immune cell types (mast cells, M1 macrophages, M2 macrophages, B cells, T helper cells, cytotoxic T cells, and regulatory T cells) in association with biochemical recurrence after radical prostatectomy. In addition to reporting a potential association between cancer‐infiltrating regulatory T cells and M1 and M2 macrophages and biochemical recurrence, the study also highlighted the use of multiplex digital pathology analyses to assess adverse predictors of prostate cancer outcomes. © 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 24, 2021
Source ID
10.1002/path.5817

Entities

People

  • Karen S Sfanos

Organizations

  • Johns Hopkins University
  • Prostate Cancer Foundation
  • Sidney Kimmel Comprehensive Cancer Center
  • United States Department of Defense

Tags

Fields of Study

  • Biology
  • Medicine

Readers

  • Immunology
  • Oncology and Biomarker-Based Cancer Detection.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.